Gold Bond Medicated Original Strength Body

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gold Bond Medicated Original Strength Body
Generic name: MENTHOL
Manufacturer: Navajo Manufacturing Company Inc.
Product type: HUMAN OTC DRUG
SPL set ID: f71d598c-92c3-d6fd-e053-6394a90a97d7
SPL ID: 23966402-d6b2-fd89-e063-6394a90ab886
Version: 2
Effective date: 2024-10-03
Source export date: 2026-09-28
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:04:05

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Gold Bond Medicated Original Strength Body	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Navajo Manufacturing Company Inc.	openfda.manufacturer_name
ndc	package	67751-225-01	openfda.package_ndc
ndc	product	67751-225	openfda.product_ndc
ndc11	package	67751022501	derived:openfda.package_ndc
rxcui		1431703	openfda.rxcui
spl id		23966402-d6b2-fd89-e063-6394a90ab886	id
spl set id		f71d598c-92c3-d6fd-e053-6394a90a97d7	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product ■ avoid contact with eyes Stop use and ask a doctor if ■ condition worsens ■ symptoms persist for more than 7 days or clear up and occur again within a few days ■ redness, irritation, swelling or pain persists or increases Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.